Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$18.1 million.

  • Medifast's Income from Continuing Operations fell 237289.84% to -$18.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$18.7 million, marking a year-over-year decrease of 100591.95%. This contributed to the annual value of -$18.7 million for FY2025, which is 99468.14% down from last year.
  • Per Medifast's latest filing, its Income from Continuing Operations stood at -$18.1 million for Q4 2025, which was down 237289.84% from -$2.3 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Income from Continuing Operations ranged from a high of $47.0 million in Q2 2021 and a low of -$18.1 million during Q4 2025
  • Moreover, its 5-year median value for Income from Continuing Operations was $24.8 million (2022), whereas its average is $19.5 million.
  • Over the last 5 years, Medifast's Income from Continuing Operations had its largest YoY gain of 13036.81% in 2025, and its largest YoY loss of 237289.84% in 2025.
  • Quarter analysis of 5 years shows Medifast's Income from Continuing Operations stood at $34.0 million in 2021, then fell by 22.06% to $26.5 million in 2022, then crashed by 77.24% to $6.0 million in 2023, then crashed by 86.79% to $797000.0 in 2024, then crashed by 2372.9% to -$18.1 million in 2025.
  • Its Income from Continuing Operations stands at -$18.1 million for Q4 2025, versus -$2.3 million for Q3 2025 and $2.5 million for Q2 2025.